Choroidal neovascularization in pathological myopia
Top Cited Papers
- 1 September 2012
- journal article
- review article
- Published by Elsevier in Progress in Retinal and Eye Research
- Vol. 31 (5), 495-525
- https://doi.org/10.1016/j.preteyeres.2012.04.001
Abstract
No abstract availableFunding Information
- National Medical Research Council (0796/2003, IRG07nov013, StaR/0003/2008, CG/SERI/2010)
This publication has 215 references indexed in Scilit:
- Macular detachment after successful intravitreal bevacizumab for myopic choroidal neovascularizationJapanese Journal of Ophthalmology, 2011
- Genome-Wide Association Studies Reveal Genetic Variants in CTNND2 for High Myopia in Singapore ChineseOphthalmology, 2011
- Comparative effects of bevacizumab, ranibizumab and pegaptanib at intravitreal dose range on endothelial cellsExperimental Eye Research, 2009
- Treatment of Exudative Age-related Macular Degeneration: Many Factors to ConsiderAmerican Journal of Ophthalmology, 2007
- Photodynamic Therapy for Nonsubfoveal Choroidal Neovascularization in 100 Eyes With Pathologic MyopiaAmerican Journal of Ophthalmology, 2007
- Combined Photodynamic Therapy and Intravitreal Triamcinolone Acetonide for the Treatment of Myopic Subfoveal Choroidal NeovascularizationAmerican Journal of Ophthalmology, 2006
- Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young femalesAmerican Journal of Ophthalmology, 2004
- Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: One-year results of an uncontrolled, prospective case seriesOphthalmology, 2002
- A study on the prevention and treatment of myopia with nacre on chicksPharmacological Research, 2001
- Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranesAmerican Journal of Ophthalmology, 1998